<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Leeds Institute of Molecular Medicine</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F3EE6643-D4FB-4083-B8F1-46833EDAF29E"><gtr:id>F3EE6643-D4FB-4083-B8F1-46833EDAF29E</gtr:id><gtr:firstName>Sandeep</gtr:firstName><gtr:surname>Uppal</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G84%2F6495"><gtr:id>A390086F-D521-44AD-843C-334C4FF5EE4B</gtr:id><gtr:title>Genetic studies on inherited diseases presenting with unusual ENT problems.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G84/6495</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>181580</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1134967</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International Resource for Autozygosity Mapping</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Sir Jules Thorn Charitable Trust</gtr:fundingOrg><gtr:id>9F3812BF-917A-4858-89FD-DF2560CC4CC0</gtr:id><gtr:outcomeId>oqveceSU8A8</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>DNA sequencing of the HPGD gene is used as a diagnostic test for pachydermoperiostosis (primary hypertrophic osteoarthropathy)</gtr:description><gtr:id>08D8C748-9D57-4E2B-B9A4-1E09C1A7A715</gtr:id><gtr:impact>An international diagnostic service for the syndrome pachydermoperiostosis at the Yorkshire Regional clinical genetics service at Leeds</gtr:impact><gtr:outcomeId>ExExDckmyqJ</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Genetic tests for pachydermoperiostosis</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.leedsth.nhs.uk/a-z-of-services/molecular-genetics/tests-by-disorder/test-pages/primary-hypertrophic-osteoarthropathy-pho/</gtr:url><gtr:yearDevCompleted>2007</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Primary hypertrophic osteoarthropathy (PHO, pachydermoperiostosis) is a defect of prostaglandin (PG) metabolism. Measurement of PGE2 excretion in the urine can now be used to monitor pharmaceutical suppression of the defect.
See P69 in URL.</gtr:description><gtr:id>22E83192-9B3F-495B-8694-69A3323331EC</gtr:id><gtr:impact>Allows titration of therapy against a biomarker directly responsible for the disease.</gtr:impact><gtr:outcomeId>dhZVwVuwiTt</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>Monitoring NSAID therapy in pachydermoperiostosis</gtr:title><gtr:type>Management of Diseases and Conditions</gtr:type><gtr:url>http://www.bsgm.org.uk/media/776072/bsgm_2013_-_programme.pdf</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>An international diagnostic testing service for the syndrome pachydermoperiostosis was developed at the Yorkshire Regional Clinical Genetics service</gtr:description><gtr:id>7E89E426-E27E-4F19-B77F-0E156E518558</gtr:id><gtr:impact>Novel mutations have been identified in follow-up publications from several other groups</gtr:impact><gtr:outcomeId>RgfTxNcVn4x</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Diagnostic testing for pachydermoperiostosis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.leedsth.nhs.uk/a-z-of-services/molecular-genetics/tests-by-disorder/test-pages/primary-hypertrophic-osteoarthropathy-pho/</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6A6E6BBA-0614-4A16-9159-01304744DBCC</gtr:id><gtr:title>Common and recurrent HPGD mutations in Caucasian individuals with primary hypertrophic osteoarthropathy.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c2b657386a4a4105e8345c404cba4b3"><gtr:id>2c2b657386a4a4105e8345c404cba4b3</gtr:id><gtr:otherNames>Diggle CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>pm_23277_27_20299379</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>697C2B06-E638-4BDA-B6B8-AEE89BE7A227</gtr:id><gtr:title>Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c2b657386a4a4105e8345c404cba4b3"><gtr:id>2c2b657386a4a4105e8345c404cba4b3</gtr:id><gtr:otherNames>Diggle CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_23277_27_22553128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A1E78B7-ADF2-45CF-9359-C64984594110</gtr:id><gtr:title>Primary Hypertrophic Osteoarthropathy: An Update on Patient Features and Treatment.</gtr:title><gtr:parentPublicationTitle>The Journal of rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9165e77c5e92958640e0b921669f77e6"><gtr:id>9165e77c5e92958640e0b921669f77e6</gtr:id><gtr:otherNames>Giancane G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0315-162X</gtr:issn><gtr:outcomeId>58c7e38fcf9cd6.65122719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>416A3E66-2447-475F-BA8F-10D48F492A52</gtr:id><gtr:title>HACE1 deficiency causes an autosomal recessive neurodevelopmental syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bed4002a489fccf8b1dcff74cfc6a496"><gtr:id>bed4002a489fccf8b1dcff74cfc6a496</gtr:id><gtr:otherNames>Hollstein R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>563b3f95eae9f3.03945823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>857E967E-AC26-442D-9989-17D89120DB8F</gtr:id><gtr:title>Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19e5a28d4de54aa5b1d2679af0b758bd"><gtr:id>19e5a28d4de54aa5b1d2679af0b758bd</gtr:id><gtr:otherNames>Uppal S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>H1x9eVkWxNp</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G84/6495</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>